 | Up a level |
Brill, A-K; von Garnier, Ch (2010). COPD-Therapie: Zwei neue Wirkstoffe erweitern das Behandlungsspektrum. Hausarztpraxis - Fortschritte der Medizin, 19 - 20. Zürich: Prime Public Media AG
von Garnier, Ch; Meyer, M; Leuppi, J; Battegay, E; Zeller, A (2010). Smoking cessation counselling: impact of chart stickers and resident training. Swiss medical weekly, 140(11-12), 175 - 80. Muttenz: EMH Schweizerischer Ärzteverlag
Azzola, A; von Garnier, Ch; Chhajed, PN; Schirp, U; Tamm, M (2010). Fatal cerebral air embolism following uneventful flexible bronchoscopy. Respiration, 80(6), 569 - 72. Basel: Karger 10.1159/000321849
von Garnier, Ch (2010). Nützt die Tabak-Rezidiv-Prävention etwas? Therapeutische Umschau, 67(8), 431 - 433. Bern: Huber
Stumbles, PA; Strickland, DH; Wikstrom, ME; Thomas, JA; von Garnier, Ch; Holt, PG (2010). Identification and isolation of rodent respiratory tract dendritic cells. Methods in molecular biology, 595, pp. 249-263. Totowa, N.J.: Humana Press
Blank, F; von Garnier, Ch (2010). Pulmonary vaccination: Dendritic cells and other antigen presenters in the lung.
Blank, F; von Garnier, Ch; Obregon, C; Rothen-Rutishauser, B; Gehr, P; Nicod, L (2008). The role of dendritic cells in the Lung: What do we know from in vitro models, animal models and human studies? Expert review of respiratory medicine, 2(2), pp. 215-233. London: Expert Reviews
